The Claim
In adults with essential hypertension who were previously uncontrolled on monotherapy, 8 weeks of treatment with 25 mg/day chlorthalidone plus 200 mg/day slow-release metoprolol results in diastolic blood pressure control (<95 mmHg) in 79.5% of patients.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among adults with high blood pressure that did not respond to a single medication, adding chlorthalidone and slow-release metoprolol together for 8 weeks brought diastolic blood pressure below 95 mmHg in 79.5% of patients.
See the scientific wording
In adults with essential hypertension, 8 weeks of treatment with 25 mg/day chlorthalidone plus 200 mg/day slow-release metoprolol achieves diastolic blood pressure control (<95 mmHg) in 79.5% of patients who were previously uncontrolled on monotherapy, indicating that adding metoprolol to non-responsive patients significantly improves therapeutic outcomes.
The diuretic removes excess salt and water from the blood, lowering the total fluid volume in the vessels. The beta-blocker slows the heart and reduces the force of each heartbeat, which decreases the pressure pushing against artery walls. Together, they reduce both the amount of fluid and the force of flow, causing blood pressure to drop.
What the research says
1 studyFor people whose high blood pressure didn’t improve with one pill (chlorthalidone), adding a second pill (metoprolol) brought their blood pressure under control in about 80% of cases — exactly what the study found.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.